Coliseum Acquisition Corp (MITAU) Prices 15M Units IPO at $10/unit
- Wall Street falls with Amazon; S&P 500 posts sixth straight month of gains
- Amazon (AMZN) Plunges After Missing Sales and Guidance Expectations, Analysts Slash PTs to Reflect Weaker Guidance
- Pinterest (PINS) Tops Profit and Sales Views, But Shares Plunges Over 20% on a Big Monthly User Miss to Prompt Two Downgrades
- 'I'm CEO.' New Book Outlines Merger Conversations Between Elon Musk and Tim Cook
- Bullard: Fed should taper this fall, go "fairly rapidly" to end early 2022
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Coliseum Acquisition Corp. (the “Company”), a special purpose acquisition company, today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and will begin trading on June 23, 2021, under the ticker symbol “MITAU”.
Each unit issued in the offering consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units commence separate trading, the Class A ordinary shares and redeemable warrants are expected to be respectively listed on Nasdaq under the symbols “MITA” and “MITAW”. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The offering is expected to close on June 25, 2021, subject to customary closing conditions.
Stifel, Nicolaus & Company, Incorporated is the sole book-running manager for the offering. The Company has granted the underwriters a 45-day option from the date of the final prospectus to purchase up to an additional 2,250,000 units at the initial public offering price to cover over-allotments, if any.
A registration statement relating to the securities became effective on June 22, 2021. The offering is being made only by means of a prospectus, which forms a part of the registration statement. Copies of the prospectus may be obtained, when available, for free by visiting EDGAR on the Securities and Exchange Commission (the “SEC”) website at www.sec.gov. Alternatively, copies may be obtained, when available, from Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate Department, One South Street, 15th Floor, Baltimore, Maryland 21202, email: email@example.com, or by telephone: (855) 300-7136.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MaxCyte, Inc. (MXCT) Prices Upsized 13.5M Share Nasdaq IPO at $13/sh
- Immuneering Corporation (IMRX) Prices 7.5M Share IPO at $15/sh
- Omega Therapeutics, Inc. (OMGA) Prices 7.4M Share IPO at $17/sh
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Related EntitiesStifel, Definitive Agreement, IPO, SPAC
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!